The Klinikum St. Georg is the oldest, and, after Leipzig University Hospital, the second largest hospital in Leipzig, Germany. It was founded in 1212. It consists of the Klinikum St. Georg gGmbH, and the Municipal Hospital "St. Georg" Leipzig.

There are 1,066 beds in Klinikum St. Georg gGMbH.

During the past decade, Klinikum St. Georg gGMbH conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum St. Georg gGMbH" #1 sponsor was "Biotronik SE & Co. KG" with 6 trials, followed by "Klinikum St. Georg gGmbH" with 3 trials sponsored, "University of Leipzig" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum St. Georg gGMbH" #1 collaborator was "Apotheke der Universitätsmedizin der Johannes Gutenberg-Universität Mainz (Germany)" with 1 trials as a collaborator, "Axel Hinke. CCRC Cancer Clinical Research Consulting (Düsseldorf, Germany" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Biotronik, Inc." with 1 trials as a collaborator and "Cyril and Methodius University in Skopje" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum St. Georg gGMbH" are "Atrial Fibrillation" (4 trials), "Heart Failure" (3 trials), "Atrial Fibrillation (AF)" (2 trials), "Lymphoma" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Klinikum St. Georg gGMbH" in a lesser frequency.

Most popular intervention types in "Klinikum St. Georg gGMbH" are "Drug" (19 trials), "Device" (12 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum St. Georg gGMbH" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum St. Georg gGMbH". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Klinikum St. Georg gGMbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum St. Georg gGMbH, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

Klinikum St. Georg gGMbH has several departments that took part in Clinical trials: "Klinikum St. Georg gGmbH Klinik fur Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie" - 2 trials, "Klinikum St.Georg gGmbH Klinik für Internistische Onkologie und Hämotologie" - 2 trials